Background and Purpose—The S2TOP-BLEED score may help to identify patients at high risk of bleeding on antiplatelet drugs after a transient ischemic attack or ischemic stroke. The score was derived on trial populations, and its performance in a real-world setting is unknown. We aimed to externally validate the S2TOP-BLEED score for major bleeding in a population-based cohort and to compare its performance with other risk scores for bleeding. Methods—We studi... Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Oxford Biomedical Research Centre
- American Heart Association Publisher's website
- Stroke Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Hilkens et al.
- Copyright date:
Copyright © 2018 The Authors.
Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
External validation of risk scores for major bleeding in a population-based cohort of transient ischemic attack and ischemic stroke patients
+ National Institute for Health Research More from this funder
Wellcome Trust More from this funder
Wolfson Foundation More from this funder
British Heart Foundation More from this funder